DOI: 10.1055/s-00000071

Seminars in Neurology

References

Gold R, Giovannoni G, Selmaj K , et al; SELECT study investigators.
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial.

Lancet 2013;
381 (9884) 2167-2175

Download Bibliographical Data

Search in:
Access: